French Govt Announces List Of ‘Critical Medicines’ Amid Growing Shortage Problem
Executive Summary
A priority list is one of the “urgent” measures the French pharma industry has called for as part of its contribution to the government’s 2023-25 roadmap for dealing with drug shortages, which is due to be published next month.
You may also be interested in...
France: Repatriating Drug Production Among Actions In ‘Roadmap’ For Tackling Shortages
The key themes of France’s latest initiative on shortages are repatriating the production of certain essential medicines and their active substances, earlier detection of potential supply problems, and more effective and transparent communications with all actors in the supply chain.
Medicines For Europe Continues To Rally For Security Of Supply
Medicines for Europe has expressed its support for a non-paper already adhered to by 21 EU member states, which proposes a number of solutions which could improve security of supply for medicines in the region.
Denmark: Critical Medicines List To Make Supply Shortage Notifications Easier
The Danish drug regulator says its new critical medicines list and notification form will make it easier for companies to notify the agency of supply shortages.